ALK-Positive Large B-Cell Lymphoma
3 clinical trials · Condition
◉ Watch ALK-Positive Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma (NCT04231877) | University of Washington | 2020-10-27 |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
Track ALK-Positive Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.